Literature DB >> 26108661

Endothelial cell tumor growth is Ape/ref-1 dependent.

Ayan Biswas1, Savita Khanna2, Sashwati Roy2, Xueliang Pan3, Chandan K Sen2, Gayle M Gordillo4.   

Abstract

Tumor-forming endothelial cells have highly elevated levels of Nox-4 that release H2O2 into the nucleus, which is generally not compatible with cell survival. We sought to identify compensatory mechanisms that enable tumor-forming endothelial cells to survive and proliferate under these conditions. Ape-1/ref-1 (Apex-1) is a multifunctional protein that promotes DNA binding of redox-sensitive transcription factors, such as AP-1, and repairs oxidative DNA damage. A validated mouse endothelial cell (EOMA) tumor model was used to demonstrate that Nox-4-derived H2O2 causes DNA oxidation that induces Apex-1 expression. Apex-1 functions as a chaperone to keep transcription factors in a reduced state. In EOMA cells Apex-1 enables AP-1 binding to the monocyte chemoattractant protein-1 (mcp-1) promoter and expression of that protein is required for endothelial cell tumor formation. Intraperitoneal injection of the small molecule inhibitor E3330, which specifically targets Apex-1 redox-sensitive functions, resulted in a 50% decrease in tumor volume compared with mice injected with vehicle control (n = 6 per group), indicating that endothelial cell tumor proliferation is dependent on Apex-1 expression. These are the first reported results to establish Nox-4 induction of Apex-1 as a mechanism promoting endothelial cell tumor formation.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  AP-1 transcription factor; DNA damage response; Nox-4; c-Jun transcription factor; endothelial cell; hemangioendothelioma; hemangioma; monocyte chemoattractant protein-1, Ape-1/ref-1; tumor cell biology

Mesh:

Substances:

Year:  2015        PMID: 26108661      PMCID: PMC4556895          DOI: 10.1152/ajpcell.00022.2015

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  60 in total

1.  Hemangioma model for in vivo angiogenesis: inducible oxidative stress and MCP-1 expression in EOMA cells.

Authors:  Gayle M Gordillo; Mustafa Atalay; Sashwati Roy; Chandan K Sen
Journal:  Methods Enzymol       Date:  2002       Impact factor: 1.600

2.  In vivo gene therapy with interleukin-12 inhibits primary vascular tumor growth and induces apoptosis in a mouse model.

Authors:  C Wang; M E Quevedo; B J Lannutti; K B Gordon; D Guo; W Sun; A S Paller
Journal:  J Invest Dermatol       Date:  1999-05       Impact factor: 8.551

3.  Oral administration of blueberry inhibits angiogenic tumor growth and enhances survival of mice with endothelial cell neoplasm.

Authors:  Gayle Gordillo; Huiqing Fang; Savita Khanna; Justin Harper; Gary Phillips; Chandan K Sen
Journal:  Antioxid Redox Signal       Date:  2009-01       Impact factor: 8.401

4.  Regulation of MCP-1 chemokine transcription by p53.

Authors:  Katrin Hacke; Bladimiro Rincon-Orozco; Gilles Buchwalter; Simone Y Siehler; Bohdan Wasylyk; Lisa Wiesmüller; Frank Rösl
Journal:  Mol Cancer       Date:  2010-04-20       Impact factor: 27.401

5.  Molecular basis of vitamin E action: tocotrienol modulates 12-lipoxygenase, a key mediator of glutamate-induced neurodegeneration.

Authors:  Savita Khanna; Sashwati Roy; Hoon Ryu; Praveen Bahadduri; Peter W Swaan; Rajiv R Ratan; Chandan K Sen
Journal:  J Biol Chem       Date:  2003-08-13       Impact factor: 5.157

6.  Nox4 redox regulation of PTP1B contributes to the proliferation and migration of glioblastoma cells by modulating tyrosine phosphorylation of coronin-1C.

Authors:  Abdus S Mondol; Nicholas K Tonks; Tohru Kamata
Journal:  Free Radic Biol Med       Date:  2013-11-13       Impact factor: 7.376

7.  Role of the multifunctional DNA repair and redox signaling protein Ape1/Ref-1 in cancer and endothelial cells: small-molecule inhibition of the redox function of Ape1.

Authors:  Meihua Luo; Sarah Delaplane; Aihua Jiang; April Reed; Ying He; Melissa Fishel; Rodney L Nyland; Richard F Borch; Xiaoxi Qiao; Millie M Georgiadis; Mark R Kelley
Journal:  Antioxid Redox Signal       Date:  2008-11       Impact factor: 8.401

8.  Redox effector factor-1, combined with reactive oxygen species, plays an important role in the transformation of JB6 cells.

Authors:  Sun Yang; Bobbye J Misner; Rita J Chiu; Frank L Meyskens
Journal:  Carcinogenesis       Date:  2007-06-12       Impact factor: 4.944

Review 9.  Transcriptional regulatory functions of mammalian AP-endonuclease (APE1/Ref-1), an essential multifunctional protein.

Authors:  Kishor K Bhakat; Anil K Mantha; Sankar Mitra
Journal:  Antioxid Redox Signal       Date:  2009-03       Impact factor: 8.401

Review 10.  The many functions of APE1/Ref-1: not only a DNA repair enzyme.

Authors:  Gianluca Tell; Franco Quadrifoglio; Claudio Tiribelli; Mark R Kelley
Journal:  Antioxid Redox Signal       Date:  2009-03       Impact factor: 8.401

View more
  11 in total

1.  Ref-1/APE1 Inhibition with Novel Small Molecules Blocks Ocular Neovascularization.

Authors:  Sheik Pran Babu Sardar Pasha; Kamakshi Sishtla; Rania S Sulaiman; Bomina Park; Trupti Shetty; Fenil Shah; Melissa L Fishel; James H Wikel; Mark R Kelley; Timothy W Corson
Journal:  J Pharmacol Exp Ther       Date:  2018-08-03       Impact factor: 4.030

2.  Urinary Excretion of MicroRNA-126 Is a Biomarker for Hemangioma Proliferation.

Authors:  Ayan Biswas; Xueliang Pan; Melissa Meyer; Savita Khanna; Sashwati Roy; Gregory Pearson; Richard Kirschner; Patricia Witman; Esteban Fernandez Faith; Chandan K Sen; Gayle M Gordillo
Journal:  Plast Reconstr Surg       Date:  2017-06       Impact factor: 4.730

3.  Phytochemical Inhibition of Multidrug Resistance Protein-1 as a Therapeutic Strategy for Hemangioendothelioma.

Authors:  Ayan Biswas; Emma C Clark; Chandan K Sen; Gayle M Gordillo
Journal:  Antioxid Redox Signal       Date:  2016-11-09       Impact factor: 8.401

4.  Multidrug Resistance-associated Protein-1 (MRP-1)-dependent Glutathione Disulfide (GSSG) Efflux as a Critical Survival Factor for Oxidant-enriched Tumorigenic Endothelial Cells.

Authors:  Gayle M Gordillo; Ayan Biswas; Savita Khanna; James M Spieldenner; Xueliang Pan; Chandan K Sen
Journal:  J Biol Chem       Date:  2016-03-09       Impact factor: 5.157

5.  Endonuclease and redox activities of human apurinic/apyrimidinic endonuclease 1 have distinctive and essential functions in IgA class switch recombination.

Authors:  Barbara Frossi; Giulia Antoniali; Kefei Yu; Nahid Akhtar; Mark H Kaplan; Mark R Kelley; Gianluca Tell; Carlo E M Pucillo
Journal:  J Biol Chem       Date:  2019-01-31       Impact factor: 5.157

6.  Mitochondria as Target for Tumor Management of Hemangioendothelioma.

Authors:  Gayle M Gordillo; Ayan Biswas; Kanhaiya Singh; Abhishek Sen; Poornachander R Guda; Caroline Miller; Xueliang Pan; Savita Khanna; Enrique Cadenas; Chandan K Sen
Journal:  Antioxid Redox Signal       Date:  2020-07-28       Impact factor: 8.401

7.  Integrin β3/Akt signaling contributes to platelet-induced hemangioendothelioma growth.

Authors:  Rui Gu; Xin Sun; Yijie Chi; Qishuang Zhou; Hongkai Xiang; Dale B Bosco; Xinhe Lai; Caixia Qin; Kwok-Fai So; Yi Ren; Xiao-Ming Chen
Journal:  Sci Rep       Date:  2017-07-25       Impact factor: 4.379

8.  Impact of the APE1 Redox Function Inhibitor E3330 in Non-small Cell Lung Cancer Cells Exposed to Cisplatin: Increased Cytotoxicity and Impairment of Cell Migration and Invasion.

Authors:  Rita Manguinhas; Ana S Fernandes; João G Costa; Nuno Saraiva; Sérgio P Camões; Nuno Gil; Rafael Rosell; Matilde Castro; Joana P Miranda; Nuno G Oliveira
Journal:  Antioxidants (Basel)       Date:  2020-06-24

9.  High nuclear expression of APE1 correlates with unfavorable prognosis and promotes tumor growth in hepatocellular carcinoma.

Authors:  Xiaohua Lu; Hui Zhao; Hongxin Yuan; Yushan Chu; Xiaoqing Zhu
Journal:  J Mol Histol       Date:  2021-01-04       Impact factor: 2.611

10.  APE1/Ref-1 redox-specific inhibition decreases survivin protein levels and induces cell cycle arrest in prostate cancer cells.

Authors:  David W McIlwain; Melissa L Fishel; Alexander Boos; Mark R Kelley; Travis J Jerde
Journal:  Oncotarget       Date:  2017-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.